Search details
1.
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.
Am J Hematol
; 99(4): 763-766, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38317312
2.
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Ann Hematol
; 102(4): 811-817, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36847805
3.
Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.
Hematol Oncol
; 40(2): 280-286, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35120267
4.
Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up.
Br J Haematol
; 194(3): 604-612, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34212373
5.
Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group.
Br J Haematol
; 193(4): 769-778, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33618437
6.
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice.
BMC Cancer
; 21(1): 73, 2021 Jan 15.
Article
in English
| MEDLINE | ID: mdl-33451293
7.
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data.
Eur J Haematol
; 107(4): 466-474, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34272773
8.
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model.
Br J Haematol
; 190(2): 189-197, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32163180
9.
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.
Haematologica
; 106(2): 601-604, 2021 02 01.
Article
in English
| MEDLINE | ID: mdl-32381580
10.
Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies.
Blood Cancer J
; 13(1): 153, 2023 09 27.
Article
in English
| MEDLINE | ID: mdl-37752128
11.
Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice.
Leuk Lymphoma
; 62(1): 194-202, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33021423
12.
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.
Leukemia
; 38(4): 893-897, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38472478
13.
Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies.
Cancer Med
; 7(8): 4132-4145, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29931775
14.
Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients - results from real-life prospective study.
Leuk Lymphoma
; 61(2): 494-496, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31580157
Results
1 -
14
de 14
1
Next >
>>